Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.
PITTSBURGH, PA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- Lou Ann P. of Alma, AR is the creator of the Book ...
Pinpointing the minimum and maximum transient noise bandwidth for a transient noise simulation is a non-trivial task. But these algorithms can help ease the challenge and ...
HealthDay on MSN
Exercise promotes release of brain-boosting protein, study shows
Key Takeaways Exercise might boost brain health by promoting the release of brain-derived neurotrophic factor (BDNF)People’s ...
HyperLight Corporation, creator of the TFLN Chiplet(TM) platform, today announced the release of its 145 GHz Packaged Intensity Modulator (IM), expanding the company's high-speed modulator portfolio.
AcuraStem, a patient-based biotechnology company developing disease-modifying therapies for amyotrophic lateral sclerosis (ALS), today announced it has received a two-year research grant from Target ...
Dr. Burkhoff will summarize the robust body of pilot study clinical evidence demonstrating sustained and reproducible systolic blood pressure reductions associated with delivery of AVIM Therapy, along ...
Researchers identify the hippocampus and microglia as the "tipping point" that determines if chronic pain leads to depression or resilience.
Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri ...
Unfortunately, Microsoft ignored the women’s feedback and pushed forward with the leering Office assistant. History has proven, that the females in the focus group were right in their assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results